27th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress
October 13-16, 2026

Hybrid Onsite Conference & Internet Event — Live and Archived
Washington Hilton
Washington, DC

Follow Pharma Congress on:  


Home

GOVERNMENT KEYNOTE SPEAKERS

Jacob Foster, JD

Acting Chief, Health Care Fraud Unit, Criminal Division, Fraud Section, US Department of Justice, Washington, DC

Veronika Peleshchuk Fradlin, MPP

Director, Transparency & Data Group, Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Washington, DC

Brenna Jenny, JD, MPH

Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US Department of Justice, Washington, DC

Twyla Mosey, PharmD, RPh

Director, Division of Advertising & Promotion Review, US Food and Drug Administration, Washington, DC

Mary E. Riordan, JD

Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC


NEW THIS YEAR:
5 IN-DEPTH, HALF-DAY, AFTERNOON FOCUSED SESSIONS, 1:00-5:30 PM ON TUESDAY 10/13

(Included in your Congress registration.)

  • Focused Session 1: Whistleblower Complaints: From Hotline to Resolution: Managing Internal Investigations, Whistleblower Risk & Escalation Decisions
  • Focused Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
  • Focused Session 3: Managing Medical-Commercial Interactions: Strategic Collaboration, Evolving Roles & Risk-Based Governance
  • Focused Session 4: AI in Action: Real-World Compliance Case Studies from the Front Lines of AI Use in Life Science Compliance Departments
  • Focused Session 5: Government Pricing Fundamentals for Compliance Officers: Navigating Today’s Evolving Pricing & Contracting Landscape


    • FEATURING ADVAMED, BIO & PHRMA UPDATES BY

    John Delacourt, JD

    Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Fmr Chief Antitrust Counsel, FTC, Washington, DC

    Ida Nassar, JD

    Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Fmr Senior Attorney, Office of Chief Counsel, US DEA, Washington, DC

    Julie Ritchie Wagner, JD

    Assistant General Counsel, PhRMA; Fmr Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC


    AND A QUI TAM COUNSEL ROUNDTABLE BY

    Mary A. Inman, JD

    Partner, Whistleblower Partners; Founding Member & Board Chair, Psst.org; Member of Advisory Board, Whistleblowing Canada Research Society, San Francisco, CA

    Linda Severin, JD

    Managing Member, Whistleblower Law Collaborative LLC; Fmr Assistant US Attorney, Southern District of New York, US DPJ, Boston, MA

    Gregg Shapiro, JD

    Founder, Gregg Shapiro Law, LLC; Fmr Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA


    ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

    Peter Agnoletto, CPA

    Compliance Officer, General Medicines and Consumer Health Care, Sanofi, Bridgewater, NJ

    Kaoutar Afif

    Manager, Ethics & Compliance, Cardinal Health, Dublin, OH

    Brian C. Barry, JD

    Vice President, Chief Compliance Officer, Vertex; Former Compliance Officer, US & Canada, EMD Serono, Boston, MA

    Allison Benkert, MBA

    Sr. Director, Compliance Policies, Training & Investigations, Jazz, Doylestown, PA

    Amy Bensten, JD

    Head of Investigations for Americas, Ethics & Compliance, Takeda, Cambridge, MA

    Brent Boeckmann, MBA

    Strategic Advisor, Commercial Immunology, Sanofi; Fmr VP, Eli Lilly – Inproteo Affiliate, Boston, MA

    Peter Brensilver, JD

    Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY

    Terra Buckley, JD

    Chief Compliance & Ethics Officer, Bristol Myers Squibb; Fmr CCO, LivaNova, Summit, NJ

    Sri Burra, MBA

    Director, US Ethics & Compliance, Organon; Fmr Ethics & Compliance Lead, NA, Haleon, Malvern, PA

    Briana Cabrera, MS, CFE

    Senior Director, Global Privacy, Medtronic; Fmr Director, Forensic Audit, Covidien, Miami, FL

    Regina Cavaliere, JD

    Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY

    Maureen Cawley, JD

    Senior Director, Corporate Counsel, Incyte; Fmr Global Agreements Attorney, Merck, Philadelphia, PA

    Jessica Constant, MS

    Associate Director, Compliance, AstraZeneca; Fmr Global Compliance Business Partner, QIAGEN, Washington, DC

    Elizabeth Conti, JD

    Senior Legal Counsel, Nestlé Health Science, Arlington, VA

    Reetu Dandora, JD

    SVP, Quality & Regulatory Compliance, AVEO; Fmr Executive Director Strategic Quality Oversight, Merck, Boston, MA

    Giulia Del Cane, MS

    Head, E&BI Projects & Compliance Officer, Enabling Functions, Global Specialty Care, Sanofi, Boston, MA

    Sharon R. Delshad, JD

    Senior Director, Legal-Compliance Counsel, Travere Therapeutics; Founder, Rebel Compliance, Del Mar, CA

    Jason DiPietro

    Senior Manager Compliance Analytics & Transparency Compliance, Lundbeck, Lake Zurich, IL

    Colleen Doyle, ACFE

    Senior Director, Risk Insights, Novo Nordisk; Fmr Senior Director, Compliance, Sage, Plainsboro, NJ

    Jennifer Dubas, JD

    CCO, Jazz; Fmr SVP & CCO, Concore; Fmr SVP & CCO, AmerisourceBergen, Ambler, PA

    Kevin Espinoza, MBA

    Chief Integrity & Compliance Officer, Indivior; Fmr CCO, Kaleo; Fmr SVP, Boston Scientific, Richmond, VA

    Patrice Ettinger, JD, CIPP/US

    VP, CPO, Regeneron; Fmr CPO, Pfizer; Fmr CPO, Avon, New York, NY

    Yelena Ferreira, JD

    Assistant GC & Head of Compliance, Pharmacosmos; Fmr Senior Director, AGC, Pacira, Morristown, NJ

    Susana Franco, MBA

    Director, Field Compliance, Lundbeck; Fmr Director, Compliance Operations, Orthofix, Dallas, TX

    Rawan Fusisi

    Head, Transparency and Third Party Compliance, Indivior; Fmr Transparency and Analytics Manager, Stryker, Washington, DC

    Julian Gabbard, JD

    Associate GC, Meso Scale; Fmr Head of Legal & Compliance, Kolon; Fmr Sr. Director, Arcellx, Washington, DC

    Naveen Ganesh, MA, JD

    VP, Global Head of Investigations, Takeda; Fmr Head of Investigations, North America & Global Specialty Care, Sanofi, Boston, MA

    Lindsey LaMoria Gavin

    Senior Director, Deputy Compliance Officer, Lundbeck; Fmr Compliance Director, Meetings & Events International, Deerfield, IL

    Jim Gibney

    Vice President, Global Compliance Operations, Regeneron; Fmr Director, Worldwide Programs, Pfizer, Ridgewood, NJ

    Jillian A. Gillespie, MBA

    Sr. Director, Compliance, Medical & Medical Affairs, Pfizer; Fmr Director, Compliance Business Partner, Seagen, Chicago, IL

    Betania Glorio, JD

    SVP & CCO, Avidity; Fmr CCO & Head, Group Compliance & Data Privacy, EMD Serono, Boston, MA

    Kate Godfrey, JD, CCEP

    SVP, Global Chief Compliance Officer, Karl Storz North America, El Segundo, CA

    Kimberly Gold, JD

    CPO & Senior AGC, Privacy Law, Genentech; Fmr Privacy Secondee, Pfizer, San Francisco, CA

    Michele Guerino, MS

    Executive Director, Ethics and Compliance Officer, Merck; Fmr Senior Regional Business Director, Cubist, Hopewell, NJ

    Tracey Hannon, JD

    Director, Compliance Business Partner, Alexion; Fmr Compliance Counsel, Ionis, Boston, MA

    Kathryn Harris, JD

    Head, US Compliance, Galderma; Fmr Senior Director, Global Compliance, Emergent, Boston, MA

    Stefanie L. Hill, JD

    Senior Director, Global Ethics & Compliance, Emergent; Fmr Senior Compliance Counsel, Prolacta, Gaithersburg, MD

    Tom Hiney, JD

    Head, Digital Ethics, US Business Unit, Takeda; Fmr Privacy Counsel, Blueprint, Boston, MA

    Marla Izbicky, JD

    Senior Director, Senior Corporate Counsel, Harmony Biosciences, Chicago, IL

    Tahvia Jenkins, JD, CIPPUS

    US Privacy Officer & Counsel, Sanofi; Fmr Assistant Counsel, University of California, Cambridge, MA

    Kathy Johnson, JD

    Vice President, Commercial and Development Legal, Vertex; Fmr, US Legal Counsel Consultant, Takeda, Boston, MA

    Melissa (Missy) Kaschak, MS, CPA, CFE, CISA

    GRC Operations, Olympus Corporations of the Americas, Center Valley, PA

    Abe Kassis, MBA, PhD

    Global Head Compliance & Legal, Bausch + Lomb; Fmr Global Compliance Director, Takeda, New York, NY

    Geeta Kaveti, MHA, JD

    CCO & US General Counsel, Nyxoah; Fmr VP, Chief Compliance & Privacy Officer, Nevro, Vernon Hills, IL

    Jeffrey Kawalek, MBA

    Chief Compliance Officer, Zambon US; Fmr Deputy CCO US, Jazz; Fmr Board Chair, PCF, New York, NY

    Peggy Kruk, HMCC

    Compliance Manager, MiMedX; Fmr Director, Compliance, Program Services, Vaniam Group, Dallas, GA

    Cheryl Lee, MBA, CHC

    Head of Compliance, Cycle; Fmr VP, ESG Strategy & Execution, BMS; Fmr VP, Compliance Worldwide, Celgene, New York, NY

    Peter Lee, JD, LLM

    Chief Compliance Officer, Kura Oncology; Fmr CCO, Mirati Therapeutics; Fmr CCO, Heron Therapeutics, San Diego, CA

    Aaron Lewis, MBA

    Director, Legal & Compliance, Cordis; Fmr Director, Compliance Insights, Cardinal Health, Miami Lakes, FL

    Melissa T. Lozner, JD

    Senior VP, CCO, Regeneron; Fmr CCO, Rafael Holdings; Fmr VP, Ethics, Novartis, Tarrytown, NY

    Christian Malias, MBA

    Assoc. Director, Compliance Program, Insmed; Fmr Assoc. Director Compliance, Sage, Pittsburgh, PA

    Danielle Manner, JD

    Chief Privacy Officer and Senior, Associate General Counsel, Gilead; Fmr Senior Privacy Counsel, Pfizer, Chicago, IL

    Rosemary McKenna, JD

    Executive Director, Regulatory Legal, Organon; Fmr Director, Regulatory-Legal, Merck, Philadelphia, PA

    Nick Merker, JD

    Vice Preesident, Assistant General Counsel, Chief Privacy Officer & Head of Digital Legal Office, Eli Lilly, Indianapolis, IN

    Michelle Murphy

    Executive Director, Compliance, Regeneron; Former Consultant, Musculoskeletal Transplant Foundation, New York, NY

    Eric Ortman, MBA

    Senior Director, Legal Operations Compliance, 4D Molecular; Fmr Senior Director, Legal Operations, BeiGene, Walnut Creek, CA

    Alison Page, JD

    Assistant General Counsel, Pfizer, New York, NY

    Al Park

    Senior Compliance Officer, Global Monitoring & Auditing, Jazz; Fmr Global Program Effectiveness, Worldwide Compliance & Business Ethics, Amgen, Phoenix, AZ

    Sandra Park, JD

    Senior Vice President, Legal & CCO, Vera; Fmr GC & CCO, IDEOlogy Health; Fmr VP, Commercial Legal, Kite, a Gilead Company, Brisbane, CA

    Joan Podleski, CCEP, CHPC, CHRC, CHC

    VP & CPO, Children’s Health System of Texas; Fmr Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX

    Lauren Ann Pond, JD

    Assistant General Counsel, BridgeBio; Fmr Commercial Counsel, Biogen; Fmr Counsel, Takeda, Palo Alto, CA

    Hannah Putnam, MHA

    Head of Ethics & Compliance Operations, Oncology, Takeda; Fmr Senior Director, Ethics & Compliance, Veloxis, Cambridge, MA

    Ariadna Quesada, MSJ

    VP, Compliance, Global Compliance & Privacy, ZOLL; Fmr Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain

    Omar Richardson, MBA

    Executive Director, Compliance, Shionogi; Fmr Compliance Officer, Grünenthal, New York, NY

    Megan Roberts, CPA, MS

    Head, Integrity & Compliance, Par Health; Fmr Senior Director, Integrity, Mallinckrodt, St. Louis, MO

    Jaya Saigal

    Senior Director, C&E Policy, Education, Communications, Culture of Integrity and Ombuds, BMS, Princeton, NJ

    Alexis Shaw, ACFE

    Deputy CCO, Paratek; Fmr Global Compliance Investigations Manager, Boston Scientific, King of Prussia, PA

    R. Brett Short, CHC, CHPC, CHRC

    CCO & CPO, University of Kentucky; Past Chair, Health Care Compliance Association, Lexington, KY

    Jesse Siegel, JD

    Head of Business Ethics, Americas, Ipsen; Fmr Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA

    Matthew Stasiunas

    RAMP & Project Management Lead, Indivior; Fmr Senior Specialist, Integrity & Compliance, Kaléo, Richmond, VA

    Ronald Strauss, CIPM

    Vice President Compliance, MiMedx; Fmr Sales Leader, Eli Lilly Specialty, Marietta, GA

    Kelly J. Tope, JD, MBA

    Head, Ethics & Business Integrity Governance, Sanofi; Fmr Head, USBU Ethics & Compliance, Takeda, Boston, MA

    Emily Treanor, JD

    Head of Global Investigations & Enterprise Risk Management, Alnylam; Former Senior Legal Counsel, Global Compliance, Hess, Washington, DC

    Natasha Trifun, JD

    Head of Enterprise Compliance & Risk and Privacy, AstraZeneca; Fmr Corporate Counsel, Brazil Compliance Officer, Pfizer, Boston, MA

    Akosua Tuffour-Brown, JD

    Corporate Counsel, U.S. General Medicines, Sanofi, Washington, DC

    Betsy Wade, MPH, CHC, CHPC, CAN

    Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY

    Achsah Warren, MSJ

    Vice President Compliance, Sumitomo; Fmr Vice President Compliance, Urovant; Fmr Senior Compliance Manager, Allergan, Irvine, CA

    Kelly Willenberg, MBA, DBA, CHC, CHRC

    Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC

    Elizabeth Weiss, JD

    VP, Chief Compliance & Privacy Officer, Invivyd; Fmr Head of Compliance for Americas & EMEA, Lupin; Fmr Assistant GC, Pfizer, Livingston, NJ

    Amy Wilson, MBA, MSJ

    VP & CCO, Esperion; Fmr Head of US Compliance, MorphoSys; Fmr Director, Enterprise Compliance, Alexion, Boston, MA

    Suki Wiltman

    Vice President, Global Ethics & Compliance, Ipsen; Fmr Business Partner, Governance, Ethics & Compliance, GSK, Toronto, Canada

    Stacy E. Yeung, JD

    VP & GC, SELLAS; Fmr Assistant General Counsel, Arena Pharmaceuticals; Fmr Deputy General Counsel, DBV Technologies, New York, NY

    Olga Zinavenka, CPA, MBA

    Head of Compliance Operations, Keenova; Fmr Executive Director, Head of Compliance Operations, Endo, Paoli, PA


    FORMER GOVERNMENT OFFICIALS

    Corey R. Amundson, JD

    Partner, King & Spalding; Fmr Head, Public Integrity Section, US DOJ; Fmr Acting US Attorney, Middle District of Louisiana, Washington, DC

    David M. Blank, JD

    Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC

    Jennifer L. Bragg, JD

    Partner, Latham and Watkins; Fmr Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC

    Hui Chen, JD

    Co-Founder, Culture. Data. Ethics; Fmr Compliance Counsel Expert, US DOJ; Fmr Assistant General Counsel, Pfizer, Honolulu, HI

    Deborah A. Curtis, JD

    Partner, Arnold & Porter; Fmr Deputy GC, CIA; Fmr Deputy Chief, Counterespionage, US DOJ, Washington, DC

    Greg Demske, JD

    Partner, Goodwin Procter; Fmr Chief Counsel, Office of Inspector General, US HHS, Washington, DC

    Edward Diskant, JD

    Partner, McDermott Will & Schulte; Fmr AUSA, Southern District of New York, US DOJ, New York, NY

    Sarah A. Franklin, JD

    Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Fmr Attorney, US FTC, Washington, DC

    Gregory T. Garcia

    Executive Director, Cybersecurity Working Group, Health Sector Coordinating Council; Fmr Assistant Secretary for Cybersecurity, US DHS, Washington, DC

    Gejaa T. Gobena, JD

    Partner, Hogan Lovells Cadwalader; Fmr Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

    Christine Gordon, JD

    VP, Risk, Assurance, & Compliance and CCO, Olympus; Fmr Assistant District Attorney, Philadelphia DA’s Office, Bethlehem, PA

    Adam Greene, JD, MPH

    Partner & Co-chair, HIPAA Practice, Davis Wright Tremaine; Fmr Senior HIT & Privacy Specialist, OCR, HHS, Washington, DC

    Kristie Gurley, JD

    Partner Covington & Burling; Fmr Counsel, Office of the General Counsel, CMS Division, US Department of HHS, Washington, DC

    Sarah M. Hall, JD

    Partner, Member of the Firm, Epstein Becker Green; Fmr Trial Attorney, Fraud Section, Criminal Division, US DOJ, Washington, DC

    Stewart Kameen, JD

    Partner, Davis Wright Tremaine; Fmr Senior Counsel, Industry Guidance Branch, OIG, HHS, Washington, DC

    Shannon Kelley, JD

    EVP, Chief Legal Officer, Madrigal; Fmr AUSA & Deputy Chief of Litigation, US Attorney’s Office District of Massachusetts, Boston, MA

    John Kelly, JD

    Partner & Chair, Healthcare Practice, Barnes & Thornburg; Fmr Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

    Barbara A. Leaf, JD

    Senior Int’l Advisor, Arnold & Porter; Fmr Special Assistant to the President; Fmr US Ambassador, UAE, Washington, DC

    Christine Moundas, JD

    Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Fmr Analyst, OIG, US HHS, New York, NY

    Preeya Noronha Pinto, JD

    Partner, DLA Piper; Fmr Acting General Counsel, US Department of Health and Human Services, Washington, DC

    Kenneth A. Polite, Jr, JD

    Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Fmr Assistant Attorney General, Criminal Division, US DOJ, Washington, DC

    David J. Scott, MS

    Managing Director, EY; Fmr Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA

    Diane Seol, JD

    Of Counsel, Choate Hall & Stewart; Fmr AUSA, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA

    Michael L. Shaw, JD

    Global Head of Compliance, Privacy and Risk, ZS; Fmr VP & CO, GlaxoSmithKline; Fmr Senior Counsel, OIG US HHS, Princeton, NJ

    Amanda Strachan, JD

    Partner, WilmerHale; Fmr AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA

    Julie K. Taitsman, MD, JD

    Managing Director, BDO, US; Fmr CMO, HHS OIG; Fmr Special Counsel, US Senate Committee on Finance, Washington, DC

    Jane H. Yoon, JD

    Partner, Litigation Department, Paul Hastings; Fmr Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY

    Heather Young, JD

    Senior Director, Compliance Officer, Global Business Partner, Olympus; Fmr Philadelphia Assistant DA, Center Valley, PA


    COMPLIANCE EXPERTS, ADVISORS AND COUNSEL

    Warren T. Allen II, JD

    Principal, Miles & Stockbridge, Washington, DC

    David Amendola

    Director, Life Sciences, Resolution Economics; Fmr Global Compliance, ConvaTec, New York, NY

    Eliza L. Andonova, JD

    Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC

    Minna Bak, MBA

    Director, HELIO, Boston, MA

    Brett Barlag, MBA

    Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

    Samantha Barrett Badlam, JD

    Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

    Yogesh Bahl, MBA

    Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY

    Melissa Bianchi, JD

    Partner and Leader, Firm’s Digital Health Initiative, Hogan Lovells Cadwalader, Washington, DC

    Craig B. Bleifer, JD

    Partner, McGuire Woods; Fmr Corporate VP, GC North America; Novo Nordisk, New York, NY

    Brian A. Bohnenkamp, MHA, JD

    Partner, FDA and Life Sciences, King & Spalding, Washington, DC

    Eric Bolesh

    Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

    Mary Capizzi, JD, MBA

    Partner, Faegre Drinker; GC, International Pharmaceutical & Medical Device Privacy Consortium, Washington, DC

    Jennifer Ceglinski, JD, CFE

    Manager, Forensic & Integrity Services, EY, Charlotte, NC

    Matthew Chandler, JD

    Director, Epsilon Life Sciences, Richmond, VA

    Michael Clarke, JD, CCEP, NACD.DC®

    Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec, Bridgewater, NJ

    Chris Cobourn, MS

    Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL

    Benjamin Correa, JD

    Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC

    Zachary Coseglia, JD

    Co-Founder, Culture. Data. Ethics; Fmr VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA

    Layla Covington, JD

    Senior Manager, Compliance Consulting, Cresen; Fmr Manager, Aggregate Spend, Genentech, Chicago, IL

    Clarissa Crain

    Managing Director, Deloitte, Phoenixville, PA

    Kari Czeszewski, CHC

    Associate, Epsilon Life Sciences, New York, NY

    Jamie E. Darch, JD

    Partner, HIPAA and State Data Privacy & Cybersecurity Law, Ropes & Gray, Chicago, IL

    Meena Datta, JD

    Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

    Mahnu V. Davar, MA, JD

    Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

    Audrey DeGuarde, MSJ

    Vice President, General Manager, Commercial Compliance, MediSpend, Morristown, NJ

    Stefanie A. Doebler, JD

    Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

    Joy Dowdle, JD

    Partner, Litigation Department, Paul Hastings and Co-Chair of the Houston Office, Houston, TX

    Kip Ebel, MBA

    Principal, Forensic & Integrity Services, EY, New York, NY

    Aurelie Ercoli, LLM, PhD

    Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC

    Ronnie H. Feldman

    Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL

    Alison J. Fethke, JD

    Member, Epstein Becker Green; Fmr Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL

    David Fisher, MS

    President, TDI Solutions; Fmr VP & General Manager, Cyber Innovations, Battelle, Washington, DC

    Sara K. Frank, JD

    Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

    Gary F. Giampetruzzi, JD

    Partner & Global Chair Life Sciences, Paul Hastings; Fmr VP & AGC, Head of Government Investigations, Pfizer, New York, NY

    John Gitas, MBA

    Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY

    Noah C. Goldstein, JD

    Counsel, Pharma, Biotech & Medical Device Legal, Regulatory, & Compliance, Porzio Bromberg & Newman, Westborough, MA

    Anthony Greco, MBA

    Managing Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA

    Asha Green, JD, MPA

    Director, US Compliance, Ferring; Fmr Global Head, I&C Risk Assessment & Senior Business Advisor, Indivior, Parsippany, NJ

    Neeraj Gupta, MBA

    President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

    Kris Hall, JD, CIPP/CIPM

    Managing Director, Dovetail; Fmr VP, Chief Privacy Officer, Celgene; Fmr VP, Head of Privacy, Shire, Bridgton, ME

    Kristin M. Hicks, JD

    Partner, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

    Emily F. Hodge, JD

    Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

    Casey J. Horton, CFE

    Managing Director, Epsilon Life Sciences; Fmr Director, Compliance Operations, AbbVie, Chicago, IL

    Jeff Hyre

    Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO

    Katie Jacyna

    Vice President, Chief Product Officer, HELIO, Denver, CO

    Mark A. Jensen, JD

    Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC

    Erin Brown Jones, MA, JD

    Partner, Latham & Watkins, Washington, DC

    Marci Juneau, MBA

    A Founding Partner, Helio Health Group, Atlanta, GA

    Kristin Graham Koehler, JD

    Managing Partner, DC Office & Executive Committee Member, Sidley Austin, Washington, DC

    Olivia Krzeminski, JD

    Director of Compliance & Legal Research, G&M Health, Somerset, NJ

    Rebekah Latchis, JD

    VP, Risk Intelligence & Investigations – Office of Integrity, Privacy and Compliance, Medtronic, Washington, DC

    Stephanie Lewko, CFE

    Managing Director, Ankura, Washington, DC

    Jeffrey Low, RPh, MHA

    Director, Ankura; Fmr VP, Clinical Services, Magellan Health; Fmr Director, Medicare Services, CVS/Caremark, Phoenix, AZ

    Courtney Lyles

    Manager, Privacy and Data Protection, Dovetail Consulting Group, Atlanta, GA

    Stephanie Macholtz, JD

    Faculty, Suffolk University Law School; Fmr VP, Compliance, Organogenesis; Fmr Senior Director Global Compliance, Apellis, Cambridge, MA

    Gabe Maldoff, JD

    Partner, Data, Privacy, and Cybersecurity practice, Goodwin Procter; Adjunct Professor, Maine Law School, Washington, DC

    Robert Melillo, JD

    Co-founder and Managing Director, G&M Health, Cocoa Beach, FL

    Brook Mishler, RN, MSN

    Global Director of Compliance Solutions, Life Sciences, Case IQ; Fmr Compliance Officer for the Americas, Cordis, Ontario, Canada

    Tracy Mumpower

    Director, Life Science Revenue, Government Pricing, HELIO; Fmr Manager, Commercial Contract Admin, King, Bristol, VA

    Katherine C. Norris, MPA

    Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI

    Daniel O’Connor

    Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

    Michael T. O’Connor

    Chief Executive Officer, Qordata; Angel Investor, Angel Investor Forum, New York, NY

    John Poulin

    Chief Technology Officer and Partner, Helio Health Group, Boston, MA

    Adam T. Oakley

    Senior Director, Potomac River Partners, Washington, DC

    Saraswatha Lalitha Putcha, MA

    Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA

    John S. Rah, JD

    Counsel and Head, Life Sciences Compliance Practice, Potter & Murdock, Potomac, MD

    Georgia Ravitz, JD

    Partner, FDA & Healthcare Regulatory, Orrick, Herrington & Sutcliffe, Washington, DC

    Nikki Reeves, JD

    Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

    Michael Reyes

    Director, Risk & Regulatory Consulting, PwC; Fmr Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX

    Brian Riewerts, MPA

    Partner, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC, Washington, DC

    Russell Rose, JD

    Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX

    Mark Scallon, MHA

    Principal, Risk Advisory, Life Sciences Consulting, Compliance and Ethics Market Leader, Baker Tilly, Richmond, VA

    Russell Schaefer, MBA

    Managing Director, BCG, Washington, DC

    Jeffrey Scott, JD

    Of Counsel, DLA Piper; Fmr Lead Compliance Counsel Digital, Pfizer, Philadelphia, PA

    Kala Shankle, JD

    VP, Regulatory, Healthcare Distribution Alliance; President Elect, American Society Pharmacy Law, Wash., DC

    Paul Silver

    Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

    Emily (Jaffe) Singh

    Partner, Global Spend Transparency Practice Leader, PwC, Chicago, IL

    Laura A. Skinner, MBA

    Managing Director, Life Sciences Consulting, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY

    Ravneet Talwar, MBA

    Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY

    Stephanie Trunk, JD

    Partner, Life Science Practice Group, Arent Fox Schiff; Fmr Legal Counsel, Catalyst Health Solutions, Washington, DC

    Brian Van Hoy, RPh

    Vice President of Compliance, G&M Health; Fmr Director Compliance & Ethics, Eli Lilly, Somerset, NJ

    L. Stephan Vincze, JD, LLM, MBA

    President & CEO, TRESTLE Compliance; Fmr SVP & CCO, Warner Chilcot; Fmr VP & CCO, TAP, Boston, MA

    Erin Wagenberg, CIPP/US, CIPP/E, CIPT

    Director, Dovetail Consulting Group; Fmr Deputy Privacy Officer, Deloitte Global, Atlanta, GA

    Shannon Walker

    Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada

    Robert A. Wells, JD

    Health Shareholder, Chair, Health Law Solutions, Baker, Donelson, Bearman, Caldwell & Berkowitz, Baltimore, MD

    Sarah L. Whipple, JD

    Principal, WhipEdge Solutions; Member, Rare Disease Compliance Consortium; Fmr VP, GCCO, Apellis, Needham, MA

    Kelly Willenberg, MBA, DBA, CHC

    Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

    Jacob Wolf, MBA

    Chief Commercial Officer, Cresen Solutions, Orlando, FL

    Christina Woods, MHA

    Partner, Pharmaceutical and Life Sciences Risk & Regulatory Consulting, PwC, New York, NY

    Cobun Zweifel-Keegan, JD

    Managing Director, IAPP; Fmr Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC


    THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

    Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.



    A HYBRID CONFERENCE AND INTERNET EVENT